Induction_NN
of_IN
the_DT
POU_NN
domain_NN
transcription_NN
factor_NN
Oct-2_NN
during_IN
T-cell_NN
activation_NN
by_IN
cognate_JJ
antigen_NN
._.

Oct-2_NN
is_VBZ
a_DT
transcription_NN
factor_NN
that_WDT
binds_VBZ
specifically_RB
to_TO
octamer_NN
DNA_NN
motifs_NNS
in_IN
the_DT
promoters_NNS
of_IN
immunoglobulin_NN
and_CC
interleukin-2_NN
genes_NNS
._.

All_DT
tumor_NN
cell_NN
lines_NNS
from_IN
the_DT
B-cell_NN
lineage_NN
and_CC
a_DT
few_JJ
from_IN
the_DT
T-cell_NN
lineage_NN
express_VBP
Oct-2_NN
._.

To_TO
address_VB
the_DT
role_NN
of_IN
Oct-2_NN
in_IN
the_DT
T-cell_NN
lineage_NN
,_,
we_PRP
studied_VBD
the_DT
expression_NN
of_IN
Oct-2_NN
mRNA_NN
and_CC
protein_NN
in_IN
nontransformed_JJ
human_JJ
and_CC
mouse_NN
T_NN
cells_NNS
._.

Oct-2_NN
was_VBD
found_VBN
in_IN
CD4_NN
+_JJ
and_CC
CD8_NN
+_CC
T_NN
cells_NNS
prepared_VBN
from_IN
human_JJ
peripheral_JJ
blood_NN
and_CC
in_IN
mouse_NN
lymph_NN
node_NN
T_NN
cells_NNS
._.

In_IN
a_DT
T-cell_NN
clone_NN
specific_JJ
for_IN
pigeon_NN
cytochrome_NN
c_NN
in_IN
the_DT
context_NN
of_IN
I-Ek_NN
,_,
Oct-2_NN
was_VBD
induced_VBN
by_IN
antigen_NN
stimulation_NN
,_,
with_IN
the_DT
increase_NN
in_IN
Oct-2_NN
protein_NN
seen_VBN
first_RB
at_IN
3_CD
h_NN
after_IN
activation_NN
and_CC
continuing_VBG
for_IN
at_IN
least_JJS
24_CD
h_NN
._.

Oct-2_NN
mRNA_NN
induction_NN
during_IN
antigen-driven_JJ
T-cell_NN
activation_NN
was_VBD
blocked_VBN
by_IN
cyclosporin_NN
A_NN
,_,
as_RB
well_RB
as_IN
by_IN
protein_NN
synthesis_NN
inhibitors_NNS
._.

These_DT
results_NNS
suggest_VBP
that_IN
Oct-2_NN
participates_VBZ
in_IN
transcriptional_JJ
regulation_NN
during_IN
T-cell_NN
activation_NN
._.

The_DT
relatively_RB
delayed_VBN
kinetics_NNS
of_IN
Oct-2_NN
induction_NN
suggests_VBZ
that_IN
Oct-2_NN
mediates_VBZ
the_DT
changes_NNS
in_IN
gene_NN
expression_NN
which_WDT
occur_VBP
many_JJ
hours_NNS
or_CC
days_NNS
following_VBG
antigen_NN
stimulation_NN
of_IN
T_NN
lymphocytes_NNS
._.

